CLINICAL_TRIALS
withdrawal
· 2018-02-28
Clinical Trial Update: Treatment With IV Iron in Hospitalized Patients With Severe Heart Failure But Without Iron Deficiency [Phase 4]
Summary
A Phase 4 clinical trial evaluating intravenous iron in hospitalized patients with severe heart failure without iron deficiency has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Heart Failure | Phase 4 | Status: WITHDRAWN